Carregando...
Safety issues and harmful pharmacological interactions of nutritional supplements in Duchenne muscular dystrophy: considerations for Standard of Care and emerging virus outbreaks
At the moment, little treatment options are available for Duchenne muscular dystrophy (DMD). The absence of the dystrophin protein leads to a complex cascade of pathogenic events in myofibres, including chronic inflammation and oxidative stress as well as altered metabolism. The attention towards di...
Na minha lista:
| Publicado no: | Pharmacol Res |
|---|---|
| Principais autores: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier Ltd.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7261230/ https://ncbi.nlm.nih.gov/pubmed/32485610 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.phrs.2020.104917 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|